Onset of systemic lupus erythematosus after conversion of infliximab to adalimumab treatment in rheumatoid arthritis with a pre-existing anti-dsDNA antibody level.

Translated title of the contribution: Onset of systemic lupus erythematosus after conversion of infliximab to adalimumab treatment in rheumatoid arthritis with a pre-existing anti-dsDNA antibody level.

A.W.A.M. van Rijthoven, J.W.J. Bijlsma, M.R. Canninga - van Dijk, R.H.W.M. Derksen, J.A.G. van Roon

Research output: Contribution to journalArticleAcademicpeer-review

Translated title of the contributionOnset of systemic lupus erythematosus after conversion of infliximab to adalimumab treatment in rheumatoid arthritis with a pre-existing anti-dsDNA antibody level.
Original languageUndefined/Unknown
Pages (from-to)1317-1318
Number of pages2
JournalRheumatology (Oxford, England)
Volume45
Publication statusPublished - 2006

Cite this